A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts

BMC Biotechnology

Volumn 9, Issue , 2009, Pages

  Bonci, Francesca ^a   Zabogli, Elisa ^a   Conti, Francesca ^a   Merico, Antonio ^a   Freer, Giulia ^a   Bendinelli, Mauro ^a   Pistello, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODELS; ANIMAL SPECIES; BICISTRONIC VECTORS; CLASS I; CYTOTOXIC T LYMPHOCYTES; EFFECTOR CELLS; ENVELOPE PROTEINS; GREEN FLUORESCENT PROTEINS; HUMAN IMMUNO DEFICIENCY VIRUS; IMMUNODEFICIENCY VIRUS; MICROBIAL INFECTIONS; NOVEL METHODS; SIMIAN VIRUS; SPONTANEOUS RELEASE; TARGET CELLS; TRANS-GENES; TRANSDUCING; VESICULAR STOMATITIS VIRUS; VIRAL ENVELOPE PROTEINS;

ANTIGENS; ASSAYS; CELL CULTURE; CELLS; CHROMIUM; CLONING; FLOW CYTOMETRY; INTERNET; VIRUSES;

TARGETS;

GREEN FLUORESCENT PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CELL CULTURE; CELL IMMORTALIZATION; CISTRON; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOMESTIC ANIMAL; FELINE IMMUNODEFICIENCY VIRUS; FLOW CYTOMETRY; GENE VECTOR; GENETIC TRANSFECTION; HOST CELL; LYMPHOCYTE FUNCTION; NONHUMAN; OUTBRED STRAIN; REPORTER GENE; SKIN FIBROBLAST; TARGET CELL; VIRUS INFECTION; ANIMAL; CAT DISEASE; CELL LINE; CYTOTOXICITY TEST; GENETIC TRANSDUCTION; IMMUNOLOGY; METHODOLOGY; VIROLOGY;

ANIMALIA; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; SIMIAN VIRUS 40; VESICULAR STOMATITIS VIRUS;

ANIMALS; CATS; CELL LINE, TRANSFORMED; CYTOTOXICITY TESTS, IMMUNOLOGIC; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FLOW CYTOMETRY; GENE PRODUCTS, ENV; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IMMUNODEFICIENCY VIRUS, FELINE; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

EID: 63649144189     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-9-18     Document Type: Article

References (32)

1. Doherty PC Turner SJ The challenge of viral immunity Immunity 2007, 27:363-365. 10.1016/j.immuni.2007.08.011 17892844
2. Koup RA Safrit JT Cao Y Andrews CA McLeod G Borkowsky W Farthing C Ho DD Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J Virol 1994, 68:4650-4655. 236393 8207839
3. Letvin NL Correlates of immune protection and the development of a human immunodeficiency virus vaccine Immunity 2007, 27:366-369. 10.1016/ j.immuni.2007.09.001 17892845
4. Deeks SG Walker BD Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy Immunity 2007, 27:406-416. 10.1016/j.immuni.2007.08.010 17892849
5. Brunner KT Mauel J Cerottini JC Chapuis B Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs Immunology 1968, 14:181-196. 1409286 4966657
6. 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues Clin Exp Immunol 2002 130 172-182 1906532 12390303 10.1046/ j.1365-2249.2002.01981.x
7. Chahroudi A Silvestri G Feinberg MB Measuring T cell-mediated cytotoxicity using fluorogenic caspase substrates Methods 2003, 31:120-126. 10.1016/S1046-2023(03)00121-X 12957569
8. Chen K Chen L Zhao P Marrero L Keoshkerian E Ramsay A Cui Y FL-CTL assay: Fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells J Immunol Methods 2005, 300:100-114. 10.1016/ j.jim.2005.02.010 15899496
9. Godoy-Ramirez K Makitalo B Thorstensson R Sandstrom E Biberfeld G Gaines H A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry Cytometry A 2005, 68:71-80. 16228974
10. Kienzle N Olver S Buttigieg K Kelso A The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers J Immunol Methods 2002, 267:99-108. 10.1016/ S0022-1759(02)00150-3 12165431
11. van Baalen CA Kwa D Verschuren EJ Reedijk ML Boon AC de Mutsert G Rimmelzwaan GF Osterhaus AD Gruters RA Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity J Infect Dis 2005, 192:1183-1190. 10.1086/444546 16136460
12. Wang Y Korkeamaki M Vainio O A novel method to analyze viral antigen-specific cytolytic activity in the chicken utilizing flow cytometry Vet Immunol Immunopathol 2003, 95:1-9. 10.1016/ S0165-2427(03)00109-0 12969631
13. Dunham S Jarrett O FIV as a model for AIDS vaccine studies Animal Models of HIV Infection and Control New York: Springer Friedman H, Bendinelli M, Specter S 2006:293-332.
14. Sparger EE FIV as a model for HIV: An overview Animal Models of HIV Infection and Control New York: Springer Friedman H, Bendinelli M, Specter S 2006:149-237.
15. Pistello M Vannucci L Ravani A Bonci F Chiuppesi F Del Santo B Freer G Bendinelli M Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes Genet Vaccines Ther 2007, 5:8. 2075492 17880683 10.1186/1479-0556-5-8
16. Köksoy S Phipps AJ Hayes KA Mathes LE SV40 Immortalization of feline fibroblasts as targets for MHC-restricted cytotoxic T-cell assays Vet Immunol Immunopathol 2001, 79:285-295. 10.1016/S0165-2427(01)00272-0 11389962
17. Beatty JA Willett BJ Gault EA Jarrett O A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction J Virol 1996, 70:6199-6206. 190644 8709246
18. Flynn JN Dunham S Mueller A Cannon C Jarrett O Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection Vet Immunol Immunopathol 2002, 85:159-170. 10.1016/ S0165-2427(01)00425-1 11943317
19. Kooistra LH Splitter GA Killer cells of feline leukemia virus- and feline sarcoma virus-infected transformed cells: The role of NK, ADCC, and in vitro generated cytotoxic cells Cell Immunol 1985, 94:466-479. 10.1016/0008-8749(85)90271-0 2992811
20. Fischer-Fantuzzi L Scheidtmann KH Vesco C Biochemical properties of a transforming nonkariophilic T antigen and SV40 Virology 1986, 153:87-95. 10.1016/0042-6822(86)90010-3 3016988
21. Fischer-Fantuzzi L Vesco C Deletion of 43 amino acids in the NH2-terminal half of the large tumor antigen of simian virus 40 results in a non-karyophilic protein capable of transforming established cells Proc Natl Acad Sci USA 1985, 82:1891-1895. 397438 2984671 10.1073/ pnas.82.7.1891
22. Fischer-Fantuzzi L Vesco C A nonkaryophilic T antigen of SV40 can either immortalize or transform rodent cells, and cooperates better with cytoplasmic than with nuclear oncoproteins Oncogene Res 1987, 1(3):229-242. 2835734
23. Hosie MJ Beatty JA Vaccine protection against feline immunodeficiency virus: Setting the challenge Aust Vet J 2007, 85:302-303. 17685973
24. Hayes KA Köksoy S Phipps AJ Buck WR Kociba GJ Mathes LE Lentivirus-specific cytotoxic T-lymphocyte responses are rapidly lost in thymectomized cats infected with feline immunodeficiency virus J Virol 2005, 79:8237-8242. 1143713 15956569 10.1128/JVI.79.13.8237-8242.2005
25. Pistello M Bonci F Flynn JN Mazzetti P Isola P Zabogli E Camerini V Matteucci D Freer G Pelosi P Bendinelli M AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: Analysis of the accessory ORF-A protein and DNA as protective immunogens J Virol 2006, 80:8856-8868. 1563914 16940498 10.1128/JVI.00397-06
26. Flynn JN Beatty JA Cannon CA Stephens EB Hosie MJ Neil JC Jarrett O Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus AIDS Res Hum Retroviruses 1995, 11:1107-1113. 10.1089/aid.1995.11.1107 8554908
27. Matteucci D Pistello M Mazzetti P Giannecchini S Isola P Merico A Zaccaro L Rizzuti A Bendinelli M AIDS vaccination studies using feline immunodeficiency virus as a model: Immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus Vaccine 18:119-130. 10.1016/S0264-410X(99)00189-9 10501242
28. Pistello M Matteucci D Bonci F Isola P Mazzetti P Zaccaro L Merico A Del Mauro D Flynn N Bendinelli M AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine J Virol 2003 77 10740-10750 224962 14512524 10.1128/ JVI.77.20.10740-10750.2003
29. Campbell DJ Rawlings JM Koelsch S Wallace J Strain JJ Hannigan BM Age-related differences in parameters of feline immune status Vet Immunol Immunopathol 2004, 100:73-80. 10.1016/j.vetimm.2004.03.002 15182997
30. George JW Pedersen NC Higgins J The effect of age on the course of experimental feline immunodeficiency virus infection in cats AIDS Res Hum Retroviruses 1993, 9:897-905. 10.1089/aid.1993.9.897 8257637
31. Arellano M Waller KE Granulocyte-macrophage-colony-stimulating factor and other cytokines: As adjuncts to cancer immunotherapy, stem cell transplantation, and vaccines Curr Hematol Rep 2004, 3:424-431. 15496276
32. Yamamoto JK Ackley CD Zochlinski H Louie H Pembroke E Torten M Hansen H Munn R Okuda T Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines Intervirology 1991, 32:361-375. 1657826